RetroSense Therapeutics

Allergan bags an early-stage gene therapy in $60M RetroSense buyout
Endpoints
Tue, 09/6/16 - 09:53 am
Allergan
gene therapy
RetroSense Therapeutics
M&A
Gene therapy for blindness gets attention of investors
Crain's Detroit Business
Sun, 06/29/14 - 10:58 am
RetroSense Therapeutics